Huadong Medicine
Hangzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A large pharma conglomerate focused on oncology, metabolic, and cardiovascular drugs.
OncologyMetabolicCardiovascular
Technology Platform
Employs a diversified R&D strategy covering small molecules, biologics, and collaborative innovation to build its therapeutic portfolio.
Opportunities
Leveraging its strong commercial platform to launch innovative new drugs and capture significant market share in China's growing specialty care segments.
Risk Factors
Exposure to ongoing national drug pricing reforms and the high failure rate and cost associated with developing novel therapeutics.
Competitive Landscape
A leader among Chinese pharma giants, competing with Hengrui and CSPC in key therapeutic areas while facing pressure from multinationals.